Literature DB >> 14654458

Reward processing in health and Parkinson's disease: neural organization and reorganization.

Ines K Goerendt1, Andrew D Lawrence, David J Brooks.   

Abstract

It has been suggested that motivational processes mediated by dopaminergic neural systems may be relatively spared in Parkinson's disease (PD) and activation of these pathways may be of therapeutic relevance. To investigate the behavioural and neural correlates of motivation in unmedicated PD patients, we used H(2)(15)O positron emission tomography to measure brain activation patterns related to the processing of monetary rewards of different magnitudes during a spatial search task in PD patients withdrawn from medication, and age-matched healthy controls. Both groups showed increased search efficiency with increasing reward, but demonstrated different patterns of neuronal activation. In healthy controls activity in prefrontal and rhinal cortices, and thalamic activity correlated with reward magnitude. In contrast, activity in the cerebellar vermis in PD patients increased with increasing reward magnitude, suggesting it was sensitive to motivational state. We interpret these relative increases in cerebellar activation as evidence for the presence of compensatory neural mechanisms in unmedicated PD patients.

Entities:  

Mesh:

Year:  2004        PMID: 14654458     DOI: 10.1093/cercor/bhg105

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  20 in total

1.  Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation.

Authors:  Susan M Ravizza; John Goudreau; Mauricio R Delgado; Sandra Ruiz
Journal:  Cogn Affect Behav Neurosci       Date:  2012-03       Impact factor: 3.282

2.  Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction?

Authors:  Rita Z Goldstein; Nelly Alia-Klein; Dardo Tomasi; Lei Zhang; Lisa A Cottone; Thomas Maloney; Frank Telang; Elisabeth C Caparelli; Linda Chang; Thomas Ernst; Dimitris Samaras; Nancy K Squires; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

3.  The cerebellum is involved in reward-based reversal learning.

Authors:  Patrizia Thoma; Christian Bellebaum; Benno Koch; Michael Schwarz; Irene Daum
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

4.  Protracted benefit from paradoxical kinesia in typical and atypical parkinsonisms.

Authors:  L Bonanni; A Thomas; F Anzellotti; D Monaco; F Ciccocioppo; S Varanese; S Bifolchetti; M C D'Amico; A Di Iorio; M Onofrj
Journal:  Neurol Sci       Date:  2010-09-22       Impact factor: 3.307

5.  Remedial effects of motivational incentive on declining cognitive control in healthy aging and Parkinson's disease.

Authors:  Helga A Harsay; Jessika I V Buitenweg; Jasper G Wijnen; Maria J S Guerreiro; K Richard Ridderinkhof
Journal:  Front Aging Neurosci       Date:  2010-10-15       Impact factor: 5.750

Review 6.  Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

Authors:  Angelo Antonini; Roberto Cilia
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease.

Authors:  Dominik Blum; Christian la Fougère; Andrea Pilotto; Walter Maetzler; Daniela Berg; Matthias Reimold; Inga Liepelt-Scarfone
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-14       Impact factor: 9.236

8.  Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.

Authors:  Nikoletta Bódi; Szabolcs Kéri; Helga Nagy; Ahmed Moustafa; Catherine E Myers; Nathaniel Daw; György Dibó; Annamária Takáts; Dániel Bereczki; Mark A Gluck
Journal:  Brain       Date:  2009-05-04       Impact factor: 13.501

9.  The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults.

Authors:  Olivia M Farr; Sien Hu; David Matuskey; Sheng Zhang; Osama Abdelghany; Chiang-Shan R Li
Journal:  Exp Clin Psychopharmacol       Date:  2013-11-04       Impact factor: 3.157

10.  Distributed neural actions of anti-parkinsonian therapies as revealed by PET.

Authors:  I K Goerendt; A D Lawrence; M A Mehta; J S Stern; P Odin; D J Brooks
Journal:  J Neural Transm (Vienna)       Date:  2005-07-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.